Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05103722 · ClinicalTrials.gov registry record · NA
Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma
A NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05103722 is a NA study that was terminated before completion, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 2 participants.
The verdict
NCT05103722, a NA study, was terminated before completion, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The trial studies the effects of personalized home-based aerobic and resistance exercises on quality of life, changes in physical activity levels, and the change in inflammatory myokines with the exercise intervention in Interleukin 6 (IL-6), C-reactive Protein (CRP), Leptin, Transforming growth factor beta (TGF-beta), and Interferon (INF) gamma.
Interventions
- OTHER Combined Aerobic and Resistance Exercise Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2022-02-17 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05103722
The ClinicalTrials.gov registry entry for NCT05103722 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Combined Aerobic and Resistance Exercise Training is the first listed.
NCT05103722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05103722 about?
NCT05103722 is a clinical study titled "Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma". The trial studies the effects of personalized home-based aerobic and resistance exercises on quality of life, changes in physical activity levels, and the change in inflammatory myokines with the exercise intervention in Interleukin 6 (IL-6), C-reactive Protein (CRP), Leptin, Transforming growth fac...
What is the current status of trial NCT05103722?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2022-02-17. Estimated completion is 2024-04-01.
What interventions are being tested in trial NCT05103722?
The interventions under investigation include: Combined Aerobic and Resistance Exercise Training (OTHER).
Who is sponsoring clinical trial NCT05103722?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.